NCT02193503 2023-09-28MVX-ONCO-1 in Patients With Solid TumorMaxivax SAPhase 1 Active not recruiting34 enrolled
NCT00149006 2007-03-14Cell Therapy of Cancer With Allogeneic Blood Lymphocytes Activated With Recombinant Interleukin-2 (rIL-2) for Metastatic Solid TumorsHadassah Medical OrganizationPhase 2 Unknown100 enrolled